| 7816375 |
Ligands for monoamine receptors and transporters, and methods of use thereof |
Brian M. Aquila, Thomas D. Bannister, Gregory D. Cuny, James R. Hauske, Joanne M. Holland +3 more |
2010-10-19 |
|
| 7550597 |
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
Michael R. Myers, Alfred P. Spada, Martin P. Maguire |
2009-06-23 |
|
| 7517892 |
Ligands for monoamine receptors and transporters, and methods of use thereof |
Brian M. Aquila, Thomas D. Bannister, Gregory D. Cuny, James R. Hauske, Joanne M. Holland +3 more |
2009-04-14 |
$18,790,000 |
| 7511141 |
Piperidine-piperazine ligands for neurotransmitter receptors |
Heike S. Radeke |
2009-03-31 |
$9,345,000 |
| 7446115 |
Peptidomimetic ligands for cellular receptors and ion channels |
Joanne M. Holland, James R. Hauske |
2008-11-04 |
$15,639,000 |
| 7294637 |
Method of treating addiction or dependence using a ligand for a monamine receptor or transporter |
Brian M. Aquila, Thomas D. Bannister, Gregory D. Cuny, James R. Hauske, Joanne M. Holland +3 more |
2007-11-13 |
$33,507,000 |
| 7132551 |
Ligands for monoamine receptors and transporters, and methods of use thereof |
Brian M. Aquila, Thomas D. Bannister, Gregory D. Cuny, James R. Hauske, Joanne M. Holland +3 more |
2006-11-07 |
$49,038,000 |
| 7115664 |
Peptidomimetic ligands for cellular receptors and ion channels |
Joanne M. Holland, James R. Hauske |
2006-10-03 |
$44,915,000 |
| 7087623 |
Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereof |
Gregory D. Cuny, James R. Hauske, Michele L. R. Heffernan, Joanne M. Holland, Heike S. Radeke |
2006-08-08 |
$23,980,000 |
| 6992077 |
Spirocyclic ligands for sigma receptors, and libraries and methods of use thereof |
Heike S. Radeke, James R. Hauske |
2006-01-31 |
$50,683,000 |
| 6936614 |
Piperidine-piperazine ligands for neurotransmitter receptors |
Heike S. Radeke |
2005-08-30 |
$37,667,000 |
| 6846815 |
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
Michael R. Myers, Alfred P. Spada, Martin P. Maguire |
2005-01-25 |
|
| 6762177 |
Spirocyclic ligands for sigma receptors, and libraries and methods of use thereof |
Heike S. Radeke, James R. Hauske |
2004-07-13 |
$72,725,000 |
| 6713479 |
Piperidine-piperazine ligands for neurotransmitter receptors |
Heike S. Radeke |
2004-03-30 |
$71,334,000 |
| 6699866 |
Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereof |
Gregory D. Cuny, James R. Hauske, Michele L. R. Heffernan, Joanne M. Holland, Heike S. Radeke |
2004-03-02 |
$68,862,000 |
| 6645969 |
Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase |
Michael R. Myers, Alfred P. Spada, Martin P. Maguire, Asher Zilberstein, Chin-Yi Jenny Hsu +1 more |
2003-11-11 |
$2,621,000 |
| 6548637 |
Ligands for opioid receptors |
James R. Hauske, Roushan A. Hussoin |
2003-04-15 |
$9,461,000 |
| 6524347 |
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
Michael. R. Myers, Alfred P. Spada, Martin P. Maguire |
2003-02-25 |
$3,259,000 |
| 6476019 |
Spirocyclic ligands for sigma receptors, and libraries and methods of use thereof |
Heike S. Radeke, James R. Hauske |
2002-11-05 |
$4,776,000 |
| RE37650 |
Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase |
Michael R. Myers, Alfred P. Spada, Martin P. Maguire, Asher Zilberstein, Chin-Yi Jenny Hsu +1 more |
2002-04-09 |
|
| 6159978 |
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56.sup.lck tyrosine kinases |
Michael R. Myers, Alfred P. Spada, Martin P. Maguire |
2000-12-12 |
$8,944,000 |
| 6057320 |
Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase |
Alfred P. Spada, Michael R. Myers, Martin P. Maguire |
2000-05-02 |
$5,297,000 |
| RE36256 |
Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase |
Alfred P. Spada, Michael R. Myers, Martin P. Maguire |
1999-07-20 |
|
| 5795889 |
Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase |
Alfred P. Spada, Michael R. Myers, Martin P. Maguire |
1998-08-18 |
|
| 5721237 |
Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties |
Michael R. Myers, Alfred P. Spada, Martin P. Maguire |
1998-02-24 |
|